Home/Filings/4/0001209191-23-059980
4//SEC Filing

Cureton Kevin 4

Accession 0001209191-23-059980

CIK 0000883107other

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 4:00 PM ET

Size

17.9 KB

Accession

0001209191-23-059980

Insider Transaction Report

Form 4
Period: 2023-12-27
Cureton Kevin
VP Sales & Mktg & Bus Dev
Transactions
  • Award

    Common Stock (right to purchase)

    2023-12-27$0.61/sh+12,600$7,68612,600 total
    Exercise: $0.61From: 2024-12-27Exp: 2030-12-27Common Stock (12,600 underlying)
Holdings
  • Common Stock (right to purchase)

    Exercise: $0.44From: 2016-02-18Exp: 2025-02-18Common Stock (50,000 underlying)
    50,000
  • Common Stock

    100,821
  • Common Stock (right to purchase)

    Exercise: $0.52From: 2015-02-13Exp: 2024-02-13Common Stock (25,000 underlying)
    25,000
  • Common Stock (right to purchase)

    Exercise: $0.68From: 2018-02-21Exp: 2027-02-21Common Stock (50,000 underlying)
    50,000
  • Common Stock (right to purchase)

    Exercise: $0.42From: 2017-02-23Exp: 2026-02-23Common Stock (43,500 underlying)
    43,500
  • Common Stock (right to purchase)

    Exercise: $0.82From: 2019-05-23Exp: 2028-05-23Common Stock (80,000 underlying)
    80,000
  • Common Stock (right to purchase)

    Exercise: $0.51From: 2020-05-22Exp: 2029-05-22Common Stock (16,500 underlying)
    16,500
  • Common Stock (right to purchase)

    Exercise: $0.45From: 2021-06-18Exp: 2027-06-18Common Stock (90,000 underlying)
    90,000
  • Common Stock (right to purchase)

    Exercise: $4.17From: 2022-12-28Exp: 2028-12-28Common Stock (90,000 underlying)
    90,000
  • Common Stock (right to purchase)

    Exercise: $1.17From: 2023-12-20Exp: 2029-12-20Common Stock (72,000 underlying)
    72,000
Footnotes (2)
  • [F1]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
  • [F2]Following the recently reported exercise of 12,393 shares (11/24/21), and the 2nd exercise of 12,607 shares (11/26/21, reported above) this line item represents the 3rd exercise, of 25,000 shares of the total initial grant of 75,000 shares, leaving a balance of 25,000 shares remaining relating to this grant.

Issuer

NANOPHASE TECHNOLOGIES Corp

CIK 0000883107

Entity typeother

Related Parties

1
  • filerCIK 0001563513

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:00 PM ET
Size
17.9 KB